This finding contrasts with extensive literature linking low SHBG to heightened incidence of cardiometabolic disorders (hypertension, insulin resistance, type 2 diabetes, coronary heart disease and stroke) and neoplastic conditions [34, 35, 36, 37, 38]. This evidence concerns the gene SHBG and Hypertension.